Clinical Trial Recruitment Lab
The Clinical Trial Recruitment Lab (CTRL) is an interdisciplinary hub for piloting and evaluating innovative ideas with the potential to increase access to clinical trials and expand diversity in clinical trial populations. CTRL’s goal is to coordinate the resources and expertise necessary to conduct pilot projects that test novel trial recruitment strategies, disseminate findings and share best practices to speed the pace of drug development. CTRL brings together stakeholders from academia, industry and philanthropy to create a platform through which innovative ideas can be piloted and tested in the real world.
Program Leadership
-
Desi Peneva, MS
Research Program Lead, USC Schaeffer Center
-
Dana Goldman, PhD
Director, USC Schaeffer Institute
Co-Director, USC Schaeffer Center
University Professor of Public Policy, Pharmacy, and Economics, USC
-
Paul Aisen, MD
Director, Alzheimer’s Therapeutic Research Institute
Professor of Neurology, Keck School of Medicine of USC
Featured Research and Perspectives

Examining the Role of Community Engagement in Enhancing the Participation of Racial and Ethnic Minoritized Communities in Alzheimer’s Disease Clinical Trials; A Rapid Review
Systematic assessment of recruitment strategies is urgently needed to increase the evidence base around community-engaged recruitment approaches.

Reporting and Representation of Participant Demographic Information in Completed Alzheimer’s Disease Clinical Trials
Research findings highlight the need for improved recruitment strategies to include more diverse participants in Alzheimer’s clinical trials.

Recommendations To Address Key Recruitment Challenges of Alzheimer’s Disease Clinical Trials
An advisory panel of experts convened in 2020 to assess the critical challenges facing recruitment in Alzheimer’s clinical trials and develop a set of recommendations to overcome them.

Key Barriers for Clinical Trials for Alzheimer’s Disease
Alzheimer’s disease (AD) clinical trials are more complicated, costly, and slower than trials for other diseases. Addressing barriers would accelerate the approval of innovative therapies.
Opportunities
2023 Clinical Trial Recruitment Lab (CTRL) Request for Pilot Project Proposals – Closed
2024 Alzheimer’s Trial Recruitment Innovation Lab Fellowship Program — Application Closed
Ongoing Studies
Alzheimer’s Trial Recruitment Innovation Lab
News

Remote Blood Collection Shows Promise for Alzheimer’s Research
A new study shows promise for using remote blood collection to find participants for Alzheimer’s trials.

USC Receives Award to Improve Diversity and Efficiency of Alzheimer’s Clinical Trials
USC’s Clinical Trial Recruitment Lab pilots and evaluates innovative ideas to boost Alzheimer’s awareness and recruit more people of diverse backgrounds to clinical trials.

2023 Clinical Trial Recruitment Lab (CTRL) Request for Pilot Project Proposals – Closed
CTRL is seeking proposals for pilot projects that test strategies and solutions designed to address barriers to recruitment for Alzheimer’s disease clinical trials.

Interdisciplinary Hub Fosters Innovative Solutions for Improving Diversity in Clinical Trials
USC has received $5.8 million from Gates Ventures and the American Heart Association to launch a lab aimed at diversifying clinical trials.